StockNews.com Initiates Coverage on InVivo Therapeutics (NASDAQ:NVIV)
StockNews.com began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note issued to investors on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Down 5.1 % Shares of NASDAQ:NVIV opened at $0.92 on Monday. The company has a market capitalization of $2.86 […]
More Stories
Columbia Sportswear (NASDAQ:COLM) Issues Q3 Earnings Guidance
Columbia Sportswear (NASDAQ:COLM – Get Free Report) issued an update on its third quarter earnings guidance on Thursday morning. The...
Boston Beer (NYSE:SAM) Announces Quarterly Earnings Results
Boston Beer (NYSE:SAM – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $4.39 earnings per...
Bitcoin Gold Market Cap Tops $457.42 Million (BTG)
Bitcoin Gold (BTG) traded up 4.7% against the dollar during the 1-day period ending at 22:00 PM Eastern on July...
AbbVie (NYSE:ABBV) Announces Quarterly Earnings Results, Beats Estimates By $0.08 EPS
AbbVie (NYSE:ABBV – Get Free Report) posted its earnings results on Thursday. The company reported $2.65 EPS for the quarter,...
Bluzelle (BLZ) Trading 8.7% Lower Over Last Week
Bluzelle (BLZ) traded up 1% against the U.S. dollar during the one day period ending at 22:00 PM E.T. on...
Bitcoin Diamond (BCD) Tops 24-Hour Volume of $4,433.51
Bitcoin Diamond (BCD) traded 10.4% higher against the dollar during the twenty-four hour period ending at 22:00 PM Eastern on...